Deletion of Crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2

Nature Genetics

Volumn 24, Issue 4, 2000, Pages 415-419

  Kishimoto, Toshimitsu ^a,b   Radulovic, Jelena ^c   Radulovic, Marko ^c   Lin, Chijen R ^a   Schrick, Christina ^c   Hooshmand, Farideh ^a   Hermanson, Ola ^a   Rosenfeld, Michael G ^a   Spiess, Joachim ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Yoshitomi Pharmaceutical Industries Ltd   (Japan)

^c MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; EMBRYO; FEEDING BEHAVIOR; FEMALE; GENE DELETION; HORMONAL REGULATION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TRANQUILIZING ACTIVITY;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANXIETY; ANXIETY DISORDERS; BRAIN; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; EDEMA; FEEDING BEHAVIOR; FEMALE; GENE DELETION; HEAT; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INJECTIONS, INTRAVENTRICULAR; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; PHOSPHORYLATION; PITUITARY-ADRENAL SYSTEM; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RESTRAINT, PHYSICAL; SEX FACTORS; STRESS; WEIGHT GAIN;

ANIMALIA;

EID: 0034069655     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/74271     Document Type: Article

References (29)

1. Spiess, J., Rivier, J., Rivier, C. & Vale, W. Primary structure of corticotropin-releasing factor from ovine hypothalamus. Proc. Natl Acad. Sci. USA 78, 6517-6521 (1981).
2. Vale, W., Spiess, J., Rivier, C. & Rivier, J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science 213, 1394-1397 (1981).
3. Chang, C.P., Pearse, R.V., O'Connell, S. & Rosenfeld, M.G. Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron 11, 1187-1195 (1993).
4. Chen, R., Lewis, K.A., Perrin, M.H. & Vale, W.W. Expression cloning of a human corticotropin-releasing-factor receptor. Proc. Natl Acad. Sci. USA 90, 8967-8971 (1993).
5. Vita, N. et al. Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors. FEBS Lett. 335, 1-5 (1993).
6. Kishimoto, T., Pearse, R.V., Lin, C.R. & Rosenfeld, M.G. A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc. Natl Acad. Sci. USA 92, 1108-1112 (1995).
7. Perrin, M. et al. Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc. Natl Acad. Sci. USA 92, 2969-2973 (1995).
8. Lovenberg, T.W. et al. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc. Natl Acad. Sci. USA 92, 836-840 (1995).
9. Stenzel, P. et al. Identification of a novel murine receptor for corticotropin-releasing hormone expressed in the heart. Mol. Endocrinol. 9, 637-645 (1995).
10. Rossant, C.J., Pinnock, R.D., Hughes, J., Hall, M.D. & McNulty, S. Corticotropin-releasing factor type 1 and type 2α receptors regulate phosphorylation of calcium/cyclic adenosine 3′,5′-monophosphate response element-binding protein and activation of p42/p44 mitogen-activated protein kinase. Endocrinology 140, 1525-1536 (1999).
11. Timpl, P. et al. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nature Genet. 19, 162-166 (1998).
12. Smith, G.W. et al. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 20, 1093-1102 (1998).
13. Chalmers, D.T., Lovenberg, T.W. & De Souza, E.B. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J. Neurosci. 15, 6340-6350 (1995).
14. Lee, E.H.Y. & Tsai, M.J. The hippocampus and amygdala mediate the locomotor stimulating effects of corticotropin-releasing factor in mice. Behav. Neural Biol. 51, 412-423 (1989).
15. Rühmann, A., Bonk, I., Lin, C.R., Rosenfeld, M.G. & Spiess, J. Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2β-selective antisauvagine-30. Proc. Natl Acad. Sci. USA 95, 15264-15269 (1998).
16. Stenzel-Poore, M.P., Heinrichs, S.C., Rivest, S., Koob, G.F. & Vale, W.W. Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. J. Neurosci. 14, 2579-2584 (1994).
17. Baldwin, H.A., Rassnick, S., Rivier, I., Koob, G.F. & Britton, K.T. CRF antagonist reverses the 'anxiogenic' response to ethanol withdrawal in the rat. Psychopharmacology 103, 227-232 (1991).
18. Carey, M.P., Billing, A.E. & Fry, J.P. Fluctuations in responses to diazepam during the oestrus cycle in the mouse. Pharmacol. Biochem. Behav. 41, 719-725 (1992).
19. Hinks, G.L., Brown, P., Field, M., Poat, J.A. & Hughes, J. The anxiolytics CI-988 and chlordiazepoxide fail to reduce immediate early gene mRNA stimulation following exposure to the rat elevated X-maze. Eur. J. Pharmacol. 312, 153-161 (1996).
20. Radulovic, J., Kammermeier, J. & Spiess, J. Relationship between FOS production and classical fear conditioning: effects of novelty, latent inhibition and unconditioned stimulus preexposure J. Neurosci. 18, 7452-7461 (1998).
21. Fisher, L.A. Corticotropin-releasing factor: endocrine and autonomic integration of responses to stress. Trends Pharmacol. Sci. 10, 189-193 (1989).
22. Turnbull, A.V., Vale, W. & Rivier, C. Urocortin, a corticotropin-releasing factor-related mammalian peptide, inhibits edema due to thermal injury in rats. Eur. J. Pharmacol. 303, 213-216 (1996).
23. Fox, W.M. Reflex-ontogeny and behavioural development of the mouse. Animal Behav. 13, 234-264 (1965).
24. Allen, E. The oestrus cycle in the mouse. Am. J. Anat. 30, 297-371, 1922
25. Lister, R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92, 180-185 (1987).
26. Rodgers, R.J. & Johnson, N.J. Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol. Biochem. Behav. 52, 297-303 (1995).
27. Takahashi, L.K., Kalin, N.H., Vanden Burgt, J.A. & Sherman, J.E. Corticotropin-releasing factor modulates defensive-withrawal and exploratory behavior in rats. Behav. Neurosci. 103, 645-654.
28. Radulovic, J., Rühmann, A., Liepold, T. & Spiess, J. Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2. J. Neurosci. 15, 5016-5025 (1999).
29. Wei, E.T. & Thomas, H.A. Correlation of neuroendocrine and anti-edema activities of alanine-corticotropin-releasing factor analogs. Eur. J. Pharmacol. 263, 319-321 (1994).